ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
Dow Jones
43.297,03
0,91%
Euro vs US Dollar
1,04009
0,02%
Bitcoin
95.300,02
-4,03%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Jazz Pharmaceuticals PLC (JAZZ) Börsenkurse

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC (JAZZ)

NASDAQ
123,73
-0,52
(-0,42%)
Geschlossen 24 Dezember 10:00PM
Verzögert um 15 Minuten
123,73
0,00
( 0,00% )
Vor Marktöffnung: 11:13AM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
123,73
Gebot
49,74
Fragen
126,70
Volumen
15
0,00 Tagesbereich 0,00
99,06 52-Wochen-Bereich 134,17
Marktkapitalisierung
7,48B
Handelsende
123,73
Handelsbeginn
-
Letzte Trade
1
@
126.4
Letzter Handelszeitpunkt
11:13:25
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
612.159
Ausgegebene Aktien
60.454.592
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
18,03
Gewinn pro Aktie (EPS)
6,86
Erlöse
3,83B
Nettogewinn
414,83M

Über Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of met... Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.jazzpharma.com
Hauptsitz
Dublin, Irl
Gegründet
-
Jazz Pharmaceuticals PLC is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker JAZZ. The last closing price for Jazz Pharmaceuticals was US$123,73. Over the last year, Jazz Pharmaceuticals shares have traded in a share price range of US$ 99,06 to US$ 134,17.

Jazz Pharmaceuticals currently has 60.454.592 shares in issue. The market capitalisation of Jazz Pharmaceuticals is US$7,48 billion. Jazz Pharmaceuticals has a price to earnings ratio (PE ratio) of 18.03.

JAZZ Neueste Nachrichten

Weitere Nachrichten

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire DUBLIN, Dec. 17, 2024 DUBLIN, Dec. 17, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq:...

17 Dezember 2024
PR Newswire (US)

Form 8-K - Current report

16 Dezember 2024
Edgar (US Regulatory)

Jazz Pharmaceuticals Announces CEO Succession Plan

Jazz Pharmaceuticals Announces CEO Succession Plan PR Newswire DUBLIN, Dec. 16, 2024 Bruce Cozadd, Co-Founder, Chairperson and CEO, Plans to Retire as CEO Upon Appointment of Successor by the End...

16 Dezember 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

10 Dezember 2024
Edgar (US Regulatory)

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual Meeting

Jazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy...

06 Dezember 2024
PR Newswire (US)

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)

Jazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii...

05 Dezember 2024
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

04 Dezember 2024
Edgar (US Regulatory)

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024

Jazz Pharmaceuticals Announces Ziihera® (zanidatamab-hrii) Investor Webcast on December 11, 2024 PR Newswire DUBLIN, Dec. 4, 2024 DUBLIN, Dec. 4, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc...

04 Dezember 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.250.202461937156123.48124.63119.14816403123.14691698CS
40.840.683538123525122.89127.095117.8611864122.6549631CS
1215.514.3213526749108.23128.99106.21612159118.94133875CS
2616.0814.9372967952107.65128.9999.06646104113.54790531CS
522.492.05377763114121.24134.1799.06669641114.45177496CS
156-4.28-3.34348878994128.01169.9899.06598196131.40221666CS
260-29.89-19.4571019399153.6218986.88621823135.57515856CS

JAZZ - Frequently Asked Questions (FAQ)

What is the current Jazz Pharmaceuticals share price?
The current share price of Jazz Pharmaceuticals is US$ 123,73
How many Jazz Pharmaceuticals shares are in issue?
Jazz Pharmaceuticals has 60.454.592 shares in issue
What is the market cap of Jazz Pharmaceuticals?
The market capitalisation of Jazz Pharmaceuticals is USD 7,48B
What is the 1 year trading range for Jazz Pharmaceuticals share price?
Jazz Pharmaceuticals has traded in the range of US$ 99,06 to US$ 134,17 during the past year
What is the PE ratio of Jazz Pharmaceuticals?
The price to earnings ratio of Jazz Pharmaceuticals is 18,03
What is the cash to sales ratio of Jazz Pharmaceuticals?
The cash to sales ratio of Jazz Pharmaceuticals is 1,95
What is the reporting currency for Jazz Pharmaceuticals?
Jazz Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Jazz Pharmaceuticals?
The latest annual turnover of Jazz Pharmaceuticals is USD 3,83B
What is the latest annual profit for Jazz Pharmaceuticals?
The latest annual profit of Jazz Pharmaceuticals is USD 414,83M
What is the registered address of Jazz Pharmaceuticals?
The registered address for Jazz Pharmaceuticals is 15TH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, D04 E5W7
What is the Jazz Pharmaceuticals website address?
The website address for Jazz Pharmaceuticals is www.jazzpharma.com
Which industry sector does Jazz Pharmaceuticals operate in?
Jazz Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MGIHMillennium Group International Holdings Ltd
US$ 4,58
(199,35%)
11M
ADDColor Star Technology Company Ltd
US$ 4,31
(99,54%)
4,33M
AIREreAlpha Tech Corporation
US$ 2,05
(49,64%)
1,21M
LICNLichen China Limited
US$ 0,2862
(36,22%)
17,18M
WAFUWah Fu Education Group Ltd
US$ 2,30
(32,18%)
4,56M
NEUPNeuphoria Therapeutics Inc
 3,84
(-42,08%)
47,08k
HOURHour Loop Inc
US$ 2,905
(-33,98%)
233,71k
SVRESaverOne 2014 Ltd
US$ 1,09
(-27,81%)
48,57k
BAOSBaosheng Media Group Holdings Ltd
US$ 5,16
(-27,32%)
72,88k
DRCTDirect Digital Holdings Inc
US$ 2,72
(-26,68%)
166,67k
LICNLichen China Limited
US$ 0,2862
(36,22%)
17,18M
MGIHMillennium Group International Holdings Ltd
US$ 4,58
(199,35%)
11M
KWEKWESST Micro Systems Inc
US$ 0,6846
(22,95%)
5,22M
WAFUWah Fu Education Group Ltd
US$ 2,30
(32,18%)
4,56M
ADDColor Star Technology Company Ltd
US$ 4,31
(99,54%)
4,33M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
JAZZ
Jazz Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten